Outcomes of magnetic sphincter augmentation - A community hospital perspective

被引：17

作者：

Czosnyka, Nicholas M. ^{[1
]}

Buckley, F. Paul ^{[2
]}

Doggett, Stephanie L. ^{[2
]}

Vassaur, Hannah ^{[2
]}

Connolly, Erin E. ^{[3
]}

Borgert, Andrew J. ^{[4
]}

Kallies, Kara J. ^{[4
]}

Kothari, Shanu N. ^{[3
]}

机构：

[1] Gunderson Med Fdn, Dept Med Educ, Gen Surg Residency, La Crosse, WI USA

[2] Baylor Scott & White Healthcare, Heartburn & Acid Reflux Ctr, Round Rock, TX USA

[3] Gundersen Hlth Syst, Dept Gen & Vasc Surg, 1900 South Ave C05-001, La Crosse, WI 54601 USA

[4] Gunderson Med Fdn, Dept Res, La Crosse, WI USA

来源：

AMERICAN JOURNAL OF SURGERY | 2017年 / 213卷 / 06期

关键词：

Magnetic sphincter augmentation; Lower esophageal sphincter; Gastroesophageal reflux; Antireflux surgery; Postoperative outcomes; Quality of life; GASTROESOPHAGEAL-REFLUX DISEASE; LAPAROSCOPIC NISSEN FUNDOPLICATION; MANAGEMENT; THERAPY; SAFETY;

D O I：

10.1016/j.amjsurg.2016.09.044

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

Background: Magnetic sphincter augmentation (MSA) is FDA approved for the surgical treatment of GERD. While multiple reports from academic settings exist, we report the early experience from two community-based health systems. Methods: The first 102 post-trial cases of MSA were reviewed. Outcomes were compared to those in the initial clinical trial. Results: Mean follow-up duration was 7.6 months. GERD medication use decreased from 98% preoperative to 8% postoperative (P<0.001). Median GERD health-related quality of life (HRQL) improved from 27 preoperative to 5 postoperative (P<0.001). Patient satisfaction increased from 8% preoperative to 84% postoperative (P<0.001). Results were similar to the trial data. Conclusions: MSA is a safe and effective treatment for GERD, with significant improvement in quality of life. GERD-HRQL, medication reduction, operative times, and dysphagia rates were similar to other reports, demonstrating the reproducibility of MSA. Lower dilation rates may be due to refinements in technique and postoperative dietary management. (C) 2016 Elsevier Inc. All rights reserved.

引用

页码：1019 / 1023

页数：5

共 18 条

[1] Long-term safety of proton pump inhibitor therapy assessed under controlled, randomised clinical trial conditions: data from the SOPRAN and LOTUS studies [J].

Attwood, S. E. ;

Ell, C. ;

Galmiche, J. P. ;

Fiocca, R. ;

Hatlebakk, J. G. ;

Hasselgren, B. ;

Langstrom, G. ;

Jahreskog, M. ;

Eklund, S. ;

Lind, T. ;

Lundell, L. .

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2015, 41 (11) :1162-1174

[2]

Darling Gail, 2005, Thorac Surg Clin, V15, P437, DOI 10.1016/j.thorsurg.2005.04.003

[3] Use of a magnetic sphincter for the treatment of GERD: a feasibility study [J].

Ganz, Robert A. ;

Gostout, Christopher J. ;

Grudem, Jerry ;

Swanson, William ;

Berg, Todd ;

DeMeester, Tom R. .

GASTROINTESTINAL ENDOSCOPY, 2008, 67 (02) :287-294

[4] Long-term Outcomes of Patients Receiving a Magnetic Sphincter Augmentation Device for Gastroesophageal Reflux [J].

Ganz, Robert A. ;

Edmundowicz, Steven A. ;

Taiganides, Paul A. ;

Lipham, John C. ;

Smith, C. Daniel ;

DeVault, Kenneth R. ;

Horgan, Santiago ;

Jacobsen, Garth ;

Luketich, James D. ;

Smith, Christopher C. ;

Schlack-Haerer, Steven C. ;

Kothari, Shanu N. ;

Dunst, Christy M. ;

Watson, Thomas J. ;

Peters, Jeffrey ;

Oelschlager, Brant K. ;

Perry, Kyle A. ;

Melvin, Scott ;

Bemelman, Willem A. ;

Smout, Andre J. P. M. ;

Dunn, Dan .

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2016, 14 (05) :671-677

[5] Association of Proton Pump Inhibitors With Risk of Dementia A Pharmacoepidemiological Claims Data Analysis [J].

Gomm, Willy ;

von Holt, Klaus ;

Thome, Friederike ;

Broich, Karl ;

Maier, Wolfgang ;

Fink, Anne ;

Doblhammer, Gabriele ;

Haenisch, Britta .

JAMA NEUROLOGY, 2016, 73 (04) :410-416

[6] Management of the patient with incomplete response to PPI therapy [J].

Kahrilas, Peter J. ;

Boeckxstaens, Guy ;

Smout, Andre J. P. M. .

BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2013, 27 (03) :401-414

[7] Guidelines for the Diagnosis and Management of Gastroesophageal Reflux Disease [J].

Katz, Philip O. ;

Gerson, Lauren B. ;

Vela, Marcelo F. .

AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 (03) :308-328

[8] Safety analysis of first 1000 patients treated with magnetic sphincter augmentation for gastroesophageal reflux disease [J].

Lipham, J. C. ;

Taiganides, P. A. ;

Louie, B. E. ;

Ganz, R. A. ;

DeMeester, T. R. .

DISEASES OF THE ESOPHAGUS, 2015, 28 (04) :305-311

[9] The LINX® reflux management system: confirmed safety and efficacy now at 4 years [J].

Lipham, John C. ;

DeMeester, Tom R. ;

Ganz, Robert A. ;

Bonavina, Luigi ;

Saino, Greta ;

Dunn, Daniel H. ;

Fockens, Paul ;

Bemelman, Willem .

SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2012, 26 (10) :2944-2949

[10] Therapy of Gastroesophageal reflux: Evidence-based approach to antireflux surgery [J].

Lundell, Lars .

DIGESTIVE DISEASES, 2007, 25 (03) :188-196

← 1 2 →